Trial Profile
A Parallel, Open Phase Ih Study to Access the Pharmacokinetic of SP2086 in Renal Insufficiency Patients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Retagliptin (Primary)
- Indications Renal failure
- Focus Pharmacokinetics
- 08 Jul 2016 New trial record